SPASTICITY-INTRATHECAL BACLOFEN PUMP INDICATIONS

SUMMARY

1. Patients with generalized, diffuse spasticity who are unable to tolerate oral agents or other treatments.

2. Significant side-effects to oral Baclofen.

3. Positive response to test-dose of intratehcal Baclofen. Prior to implantation, patients are given a trial of intrathecal baclofen via a percutaneous catheter or bolus.

4. Used in spinal forms of spasticity, SCI, MS, TBI, stroke, CP, provided there is function below the level of the lesion.

5. Patients should be compliant for regular monitoring & refilling. Non-compliance increases risk of complications, including withdrawal.

6. If a patient has functional use of spasticity, then an ITB may not be useful.

Reference(s)

Cifu, D.X. (2020). Braddom’s physical medicine and rehabilitation. Elsevier. Get it on Amazon.
Cuccurullo, S. (2019). Physical medicine and rehabilitation board review. New York: Demosmedical. Get it on Amazon.
O’Young, B., Young, M.A. and Stiens, S.A. (2008). Physical Medicine and Rehabilitation Secrets. Mosby. Get it on Amazon.